Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

A qualitative analysis of emerging adult black men's sexual decision-making behavior and substance use.

Pass KM, Younge SN, Geter A, Al-Bayan M, Wade BH.

J Ethn Subst Abuse. 2016 Oct-Dec;15(4):386-404. Epub 2015 Dec 7.

PMID:
26643271
2.

Association between C677T polymorphism of methylene tetrahydrofolate reductase and congenital heart disease: meta-analysis of 7697 cases and 13,125 controls.

Mamasoula C, Prentice RR, Pierscionek T, Pangilinan F, Mills JL, Druschel C, Pass K, Russell MW, Hall D, Töpf A, Brown DL, Zelenika D, Bentham J, Cosgrove C, Bhattacharya S, Riveron JG, Setchfield K, Brook JD, Bu'Lock FA, Thornborough C, Rahman TJ, Doza JP, Tan HL, O'Sullivan J, Stuart AG, Blue G, Winlaw D, Postma AV, Mulder BJ, Zwinderman AH, van Engelen K, Moorman AF, Rauch A, Gewillig M, Breckpot J, Devriendt K, Lathrop GM, Farrall M, Goodship JA, Cordell HJ, Brody LC, Keavney BD.

Circ Cardiovasc Genet. 2013 Aug;6(4):347-53. doi: 10.1161/CIRCGENETICS.113.000191. Epub 2013 Jul 22.

3.

Newborn screening for autism: in search of candidate biomarkers.

Mizejewski GJ, Lindau-Shepard B, Pass KA.

Biomark Med. 2013 Apr;7(2):247-60. doi: 10.2217/bmm.12.108.

4.

A microsphere-based assay for mutation analysis of the biotinidase gene using dried blood spots.

Lindau-Shepard B, Janik DK, Pass KA.

J Pediatr Genet. 2012 Sep;1(3):153-60. doi: 10.3233/PGE-2012-025.

5.

Newborn screening for metabolic disorders: how are we doing, and where are we going?

Bennett MJ, Rinaldo P, Wilcken B, Pass KA, Watson MS, Wanders RJ.

Clin Chem. 2012 Feb;58(2):324-31. doi: 10.1373/clinchem.2011.171215. Epub 2011 Aug 24. No abstract available.

6.

Improved immunoassay for the detection of severe combined immunodeficiency.

Janik DK, Lindau-Shepard B, Nørgaard-Pedersen B, Heilmann C, Pass KA.

Clin Chem. 2011 Aug;57(8):1207-9. doi: 10.1373/clinchem.2011.162263. Epub 2011 May 13. No abstract available.

7.

Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals.

Wang RY, Bodamer OA, Watson MS, Wilcox WR; ACMG Work Group on Diagnostic Confirmation of Lysosomal Storage Diseases.

Genet Med. 2011 May;13(5):457-84. doi: 10.1097/GIM.0b013e318211a7e1.

PMID:
21502868
8.

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.

McHugh D, Cameron CA, Abdenur JE, Abdulrahman M, Adair O, Al Nuaimi SA, Åhlman H, Allen JJ, Antonozzi I, Archer S, Au S, Auray-Blais C, Baker M, Bamforth F, Beckmann K, Pino GB, Berberich SL, Binard R, Boemer F, Bonham J, Breen NN, Bryant SC, Caggana M, Caldwell SG, Camilot M, Campbell C, Carducci C, Bryant SC, Caggana M, Caldwell SG, Camilot M, Campbell C, Carducci C, Cariappa R, Carlisle C, Caruso U, Cassanello M, Castilla AM, Ramos DE, Chakraborty P, Chandrasekar R, Ramos AC, Cheillan D, Chien YH, Childs TA, Chrastina P, Sica YC, de Juan JA, Colandre ME, Espinoza VC, Corso G, Currier R, Cyr D, Czuczy N, D'Apolito O, Davis T, de Sain-Van der Velden MG, Delgado Pecellin C, Di Gangi IM, Di Stefano CM, Dotsikas Y, Downing M, Downs SM, Dy B, Dymerski M, Rueda I, Elvers B, Eaton R, Eckerd BM, El Mougy F, Eroh S, Espada M, Evans C, Fawbush S, Fijolek KF, Fisher L, Franzson L, Frazier DM, Garcia LR, Bermejo MS, Gavrilov D, Gerace R, Giordano G, Irazabal YG, Greed LC, Grier R, Grycki E, Gu X, Gulamali-Majid F, Hagar AF, Han L, Hannon WH, Haslip C, Hassan FA, He M, Hietala A, Himstedt L, Hoffman GL, Hoffman W, Hoggatt P, Hopkins PV, Hougaard DM, Hughes K, Hunt PR, Hwu WL, Hynes J, Ibarra-González I, Ingham CA, Ivanova M, Jacox WB, John C, Johnson JP, Jónsson JJ, Karg E, Kasper D, Klopper B, Katakouzinos D, Khneisser I, Knoll D, Kobayashi H, Koneski R, Kozich V, Kouapei R, Kohlmueller D, Kremensky I, la Marca G, Lavochkin M, Lee SY, Lehotay DC, Lemes A, Lepage J, Lesko B, Lewis B, Lim C, Linard S, Lindner M, Lloyd-Puryear MA, Lorey F, Loukas YL, Luedtke J, Maffitt N, Magee JF, Manning A, Manos S, Marie S, Hadachi SM, Marquardt G, Martin SJ, Matern D, Mayfield Gibson SK, Mayne P, McCallister TD, McCann M, McClure J, McGill JJ, McKeever CD, McNeilly B, Morrissey MA, Moutsatsou P, Mulcahy EA, Nikoloudis D, Norgaard-Pedersen B, Oglesbee D, Oltarzewski M, Ombrone D, Ojodu J, Papakonstantinou V, Reoyo SP, Park HD, Pasquali M, Pasquini E, Patel P, Pass KA, Peterson C, Pettersen RD, Pitt JJ, Poh S, Pollak A, Porter C, Poston PA, Price RW, Queijo C, Quesada J, Randell E, Ranieri E, Raymond K, Reddic JE, Reuben A, Ricciardi C, Rinaldo P, Rivera JD, Roberts A, Rocha H, Roche G, Greenberg CR, Mellado JM, Juan-Fita MJ, Ruiz C, Ruoppolo M, Rutledge SL, Ryu E, Saban C, Sahai I, García-Blanco MI, Santiago-Borrero P, Schenone A, Schoos R, Schweitzer B, Scott P, Seashore MR, Seeterlin MA, Sesser DE, Sevier DW, Shone SM, Sinclair G, Skrinska VA, Stanley EL, Strovel ET, Jones AL, Sunny S, Takats Z, Tanyalcin T, Teofoli F, Thompson JR, Tomashitis K, Domingos MT, Torres J, Torres R, Tortorelli S, Turi S, Turner K, Tzanakos N, Valiente AG, Vallance H, Vela-Amieva M, Vilarinho L, von Döbeln U, Vincent MF, Vorster BC, Watson MS, Webster D, Weiss S, Wilcken B, Wiley V, Williams SK, Willis SA, Woontner M, Wright K, Yahyaoui R, Yamaguchi S, Yssel M, Zakowicz WM.

Genet Med. 2011 Mar;13(3):230-54. doi: 10.1097/GIM.0b013e31820d5e67.

PMID:
21325949
9.

Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative.

Auchus RJ, Witchel SF, Leight KR, Aisenberg J, Azziz R, Bachega TA, Baker LA, Baratz AB, Baskin LS, Berenbaum SA, Breault DT, Cerame BI, Conway GS, Eugster EA, Fracassa S, Gearhart JP, Geffner ME, Harris KB, Hurwitz RS, Katz AL, Kalro BN, Lee PA, Alger Lin G, Loechner KJ, Marshall I, Merke DP, Migeon CJ, Miller WL, Nenadovich TL, Oberfield SE, Pass KA, Poppas DP, Lloyd-Puryear MA, Quigley CA, Riepe FG, Rink RC, Rivkees SA, Sandberg DE, Schaeffer TL, Schlussel RN, Schneck FX, Seely EW, Snyder D, Speiser PW, Therrell BL, Vanryzin C, Vogiatzi MG, Wajnrajch MP, White PC, Zuckerman AE.

Int J Pediatr Endocrinol. 2010;2010:275213. doi: 10.1155/2010/275213. Epub 2011 Jan 10.

10.

Diagnostic guidelines for newborns who screen positive in newborn screening.

Kronn D, Mofidi S, Braverman N, Harris K; Diagnostics Guidelines Work Group.

Genet Med. 2010 Dec;12(12 Suppl):S251-5. doi: 10.1097/GIM.0b013e3181fe5d8b.

PMID:
21150371
11.

A multiplex immunoassay using the Guthrie specimen to detect T-cell deficiencies including severe combined immunodeficiency disease.

Janik DK, Lindau-Shepard B, Comeau AM, Pass KA.

Clin Chem. 2010 Sep;56(9):1460-5. doi: 10.1373/clinchem.2010.144329. Epub 2010 Jul 21.

12.

High-throughput multiplexed T-cell-receptor excision circle quantitative PCR assay with internal controls for detection of severe combined immunodeficiency in population-based newborn screening.

Gerstel-Thompson JL, Wilkey JF, Baptiste JC, Navas JS, Pai SY, Pass KA, Eaton RB, Comeau AM.

Clin Chem. 2010 Sep;56(9):1466-74. doi: 10.1373/clinchem.2010.144915. Epub 2010 Jul 21.

13.

Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas.

Hinton CF, Harris KB, Borgfeld L, Drummond-Borg M, Eaton R, Lorey F, Therrell BL, Wallace J, Pass KA.

Pediatrics. 2010 May;125 Suppl 2:S37-47. doi: 10.1542/peds.2009-1975D.

PMID:
20435716
14.

Newborn screening for cystic fibrosis by use of a multiplex immunoassay.

Lindau-Shepard BA, Pass KA.

Clin Chem. 2010 Mar;56(3):445-50. doi: 10.1373/clinchem.2009.132480. Epub 2009 Dec 29.

15.

Update: newborn screening for endocrinopathies.

Pass KA, Neto EC.

Endocrinol Metab Clin North Am. 2009 Dec;38(4):827-37. doi: 10.1016/j.ecl.2009.08.005. Review.

PMID:
19944295
16.

Emergency preparedness for newborn screening and genetic services.

Pass KA, Thoene J, Watson MS.

Genet Med. 2009 Jun;11(6):455-64. doi: 10.1097/GIM.0b013e3181a959c1.

PMID:
19444127
17.

Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report.

Lubin IM, McGovern MM, Gibson Z, Gross SJ, Lyon E, Pagon RA, Pratt VM, Rashid J, Shaw C, Stoddard L, Trotter TL, Williams MS, Amos Wilson J, Pass K.

J Mol Diagn. 2009 Mar;11(2):162-71. doi: 10.2353/jmoldx.2009.080130. Epub 2009 Feb 5.

18.

Perinatal transfer of genetic information: developing an algorithm for reporting cystic fibrosis prenatal test results to the newborn screening program.

Regalado ES, Langfelder-Schwind E, Corwin AD, Pass KA.

Genet Med. 2008 Nov;10(11):805-10. doi: 10.1097/GIM.0b013e31818a3107.

PMID:
18941423
19.

Use of newborn screening program blood spots for exposure assessment: declining levels of perluorinated compounds in New York State infants.

Spliethoff HM, Tao L, Shaver SM, Aldous KM, Pass KA, Kannan K, Eadon GA.

Environ Sci Technol. 2008 Jul 15;42(14):5361-7.

PMID:
18754394
20.

Enhancing newborn screening for tyrosinemia type I.

Pass KA, Morrissey M.

Clin Chem. 2008 Apr;54(4):627-9. doi: 10.1373/clinchem.2008.103200. No abstract available.

Supplemental Content

Loading ...
Support Center